A multi-agent simulation of the pharmaceutical supply chain

G Jetly, C L Rossetti and R Handfield

Journal of Simulation, 2012, vol. 6, issue 4, 215-226

Abstract: The pharmaceutical supply chain is composed of multiple firms interacting to produce and distribute drugs in an uncertain environment. In this work, we develop and validate a multi-agent simulation of the supply chains associated with the pharmaceutical industry. We demonstrate that the operating norms of a particular industry can be accurately represented to create an industry-specific model capable of tracing its evolution. Our model is initialized using 1982 financial data with 30 manufacturers, 60 suppliers, and 60 distributors. Three types of drugs, blockbusters, medium and small, with a 12-year lognormal product life cycle are released by manufacturers. Each quarter the distributors bid for future market share of the released products, and the suppliers bid for acceptable margins. Mergers and acquisitions, based on assets and expected profitability, are allowed at each level. One thousand replications, each lasting the equivalent of 39 years, are used to validate the model.

Date: 2012
References: Add references at CitEc
Citations:

Downloads: (external link)
http://hdl.handle.net/10.1057/jos.2011.26 (text/html)
Access to full text is restricted to subscribers.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:taf:tjsmxx:v:6:y:2012:i:4:p:215-226

Ordering information: This journal article can be ordered from
http://www.tandfonline.com/pricing/journal/tjsm20

DOI: 10.1057/jos.2011.26

Access Statistics for this article

Journal of Simulation is currently edited by Christine Currie

More articles in Journal of Simulation from Taylor & Francis Journals
Bibliographic data for series maintained by Chris Longhurst ().